Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential

(1976) Editorial: gene cloning: one milestone on a very long road. Lancet 1:893

(1981) Gene therapy: how ripe the time? Lancet 1:196–197

Akazawa T, Ebihara T, Okuno M et al (2007a) Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA 104:252–257

Akazawa T, Shingai M, Sasai M et al (2007b) Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors. FEBS Lett 581:3334–3340

Anderson WF, Blaese RM, Culver K (1990) The ADA human gene therapy clinical protocol: points to consider response with clinical protocol, July 6, 1990. Hum Gene Ther 1:331–362

Andreadis ST, Brott D, Fuller AO et al (1997) Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J Virol 71:7541–7548

Apolonia L, Waddington SN, Fernandes C et al (2007) Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther 15:1947–1954

Avery OT, MacLeod CM, McCarty M (1979) Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med 149:297–326

Biffi A, Naldini L (2007) Novel candidate disease for gene therapy: metachromatic leukodystrophy. Expert Opin Biol Ther 7:1193–1205

Blaese RM, Culver KW, Chang L et al (1993) Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992. Hum Gene Ther 4:521–527

Blomer U, Naldini L, Kafri T et al (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71:6641–6649

Bokhoven M, Stephen SL, Knight S et al (2009) Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol 83:283–294

Bouard D, Alazard-Dany D, Cosset FL (2009) Viral vectors: from virology to transgene expression. Br J Pharmacol 157:153–165

Breckpot K, Escors D (2009) Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. Endocr Metab Immune Disord Drug Targets 9:328–343

Breckpot K, Dullaers M, Bonehill A et al (2003) Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. J Gene Med 5:654–667

Breckpot K, Corthals J, Heirman C et al (2004) Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells. Hum Gene Ther 15:562–573

Breckpot K, Aerts JL, Thielemans K (2007a) Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Gene Ther 14:847–862

Breckpot K, Emeagi P, Dullaers M et al (2007b) Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Hum Gene Ther 18:536–546

Breckpot K, Emeagi PU, Thielemans K (2008) Lentiviral vectors for anti-tumor immunotherapy. Curr Gene Ther 8:438–448

Brenner MK, Rill DR, Holladay MS et al (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134–1137

Brown BD, Cantore A, Annoni A et al (2007a) A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110:4144–4152

Brown BD, Gentner B, Cantore A et al (2007b) Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 25:1457–1467

Brown BD, Sitia G, Annoni A et al (2007c) In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109:2797–2805

Bukrinsky MI, Haggerty S, Dempsey MP et al (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666–669

Burns JC, Friedmann T, Driever W et al (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033–8037

Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669–672

Charneau P, Alizon M, Clavel F (1992) A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 66:2814–2820

Cline MJ (1985) Perspectives for gene therapy: inserting new genetic information into mammalian cells by physical techniques and viral vectors. Pharmacol Ther 29:69–92

Coil DA, Miller AD (2004) Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 78:10920–10926

Cornu TI, Cathomen T (2007) Targeted genome modifications using integrase-deficient lentiviral vectors. Mol Ther 15:2107–2113

Costantini LC, Bakowska JC, Breakefield XO et al (2000) Gene therapy in the CNS. Gene Ther 7:93–109

Cui Y, Golob J, Kelleher E et al (2002) Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood 99:399–408

De Palma M, Venneri MA, Naldini L (2003) In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. Hum Gene Ther 14:1193–1206

Deisseroth AB, Zu Z, Claxton D et al (1994) Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068–3076

Duerner LJ, Schwantes A, Schneider IC et al (2008) Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue. Gene Ther 15:1500–1510

Dull T, Zufferey R, Kelly M et al (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471

Dullaers M, Van Meirvenne S, Heirman C et al (2006) Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Gene Ther 13:630–640

Dunbar CE, Cottler-Fox M, O’Shaughnessy JA et al (1995) Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048–3057

Escors D, Lopes L, Lin R et al (2008) Targeting dendritic cell signaling to regulate the response to immunization. Blood 111:3050–3061

Falk R (1984) The gene in search of an identity. Hum Genet 68:195–204

Farson D, Witt R, McGuinness R et al (2001) A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther 12:981–997

Friedmann T (1976) The future for gene therapy—a reevaluation. Ann NY Acad Sci 265:141–152

Friedmann T, Roblin R (1972) Gene therapy for human genetic disease? Science 175:949–955

Funke S, Maisner A, Muhlebach MD et al (2008) Targeted cell entry of lentiviral vectors. Mol Ther 16:1427–1436

Galimi F, Saez E, Gall J et al (2005) Development of ecdysone-regulated lentiviral vectors. Mol Ther 11:142–148

Gascon S, Paez-Gomez JA, Diaz-Guerra M et al (2008) Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons. J Neurosci Methods 168:104–112

Gaspar HB, Parsley KL, Howe S et al (2004) Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364:2181–2187

Georgievska B, Jakobsson J, Persson E et al (2004) Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Hum Gene Ther 15:934–944

Ginn SL, Fleming J, Rowe PB et al (2003) Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner. Hum Gene Ther 14:1127–1137

Gottlieb MS (2006) Pneumocystis pneumonia—Los Angeles. 1981. Am J Public Health 96:980–981; discussion 982–983

Greenberg KP, Geller SF, Schaffer DV et al (2007) Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors. Invest Ophthalmol Vis Sci 48:1844–1852

Gruber A, Kan-Mitchell J, Kuhen KL et al (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 96:1327–1333

Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419

Hamer DH, Smith KD, Boyer SH et al (1979) SV40 recombinants carrying rabbit beta-globin gene coding sequences. Cell 17:725–735

Hatziioannou T, Delahaye E, Martin F et al (1999) Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin. Hum Gene Ther 10:1533–1544

Heinzinger NK, Bukinsky MI, Haggerty SA et al (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91:7311–7315

Hematti P, Hong BK, Ferguson C et al (2004) Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol 2:e423

Howe SJ, Mansour MR, Schwarzwaelder K et al (2008) Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118:3143–3150

Jacome A, Navarro S, Rio P et al (2009) Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol Ther 17:1083–1092

Johansen J, Rosenblad C, Andsberg K et al (2002) Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Ther 9:1291–1301

Jones IM, Morikawa Y (1998) The molecular basis of HIV capsid assembly. Rev Med Virol 8:87–95

Karwacz K, Mukherjee S, Apolonia L et al (2009) Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J Virol 83:3094–3103

Katz RA, Skalka AM (1994) The retroviral enzymes. Annu Rev Biochem 63:133–173

Keeler CE (1947) Gene therapy. J Hered 38:294–298

Korin YD, Zack JA (1998) Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 72:3161–3168

Koya RC, Kasahara N, Favaro PM et al (2003) Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery. J Immunother 26:451–460

Kuroda H, Kutner RH, Bazan NG et al (2008) A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer. J Gene Med 10:1163–1175

Lai Z, Brady RO (2002) Gene transfer into the central nervous system in vivo using a recombinant lentivirus vector. J Neurosci Res 67:363–371

Le Doux JM, Davis HE, Morgan JR et al (1999) Kinetics of retrovirus production and decay. Biotechnol Bioeng 63:654–662

Levine F, Friedmann T (1991) Gene therapy techniques. Curr Opin Biotechnol 2:840–844

Lewis PF, Emerman M (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68:510–516

Liu BH, Wang X, Ma YX et al (2004) CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Gene Ther 11:52–60

Liu B, Paton JF, Kasparov S (2008) Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo. BMC Biotechnol 8:49

Lombardo A, Genovese P, Beausejour CM et al (2007) Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25:1298–1306

Lopes L, Dewannieux M, Gileadi U et al (2008) Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. J Virol 82:86–95

Manilla P, Rebello T, Afable C et al (2005) Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 16:17–25

Mann R, Mulligan RC, Baltimore D (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153–159

Mantei N, Boll W, Weissmann C (1979) Rabbit beta-globin mRNA production in mouse L cells transformed with cloned rabbit beta-globin chromosomal DNA. Nature 281:40–46

Mantovani J, Charrier S, Eckenberg R et al (2009) Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med 11:645–654

Marangoni F, Bosticardo M, Charrier S et al (2009) Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol Ther 17:1073–1082

Menzel O, Birraux J, Wildhaber BE et al (2009) Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol Ther 17:1754–1760

Mercola KE, Cline MJ (1980) Sounding boards. The potentials of inserting new genetic information. N Engl J Med 303:1297–1300

Miyoshi H, Takahashi M, Gage FH et al (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 94:10319–10323

Miyoshi H, Blomer U, Takahashi M et al (1998) Development of a self-inactivating lentivirus vector. J Virol 72:8150–8157

Modlich U, Navarro S, Zychlinski D et al (2009) Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 17:1919–1928

Montini E, Cesana D, Schmidt M et al (2009) The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119:964–975

Moreau-Gaudry F, Xia P, Jiang G et al (2001) High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors. Blood 98:2664–2672

Moreno-Carranza B, Gentsch M, Stein S et al (2009) Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther 16:111–118

Morgan RA, Dudley ME, Wunderlich JR et al (2006) Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126–129

Morizono K, Xie Y, Ringpis GE et al (2005) Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 11:346–352

Mortellaro A, Hernandez RJ, Guerrini MM et al (2006) Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. Blood 108:2979–2988

Mulligan RC, Howard BH, Berg P (1979) Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature 277:108–114

Nagata S, Taira H, Hall A et al (1980) Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 284:316–320

Naldini L, Blomer U, Gage FH et al (1996a) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382–11388

Naldini L, Blomer U, Gallay P et al (1996b) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267

Neville R (1976) Gene therapy and the ethics of genetic therapeutics. Ann NY Acad Sci 265:153–169

Ochoa S (1963) Synthetic polynucleotides and the genetic code. Proc Can Cancer Conf 5:37–64

Oertel M, Rosencrantz R, Chen YQ et al (2003) Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology 37:994–1005

Palu G, Parolin C, Takeuchi Y et al (2000) Progress with retroviral gene vectors. Rev Med Virol 10:185–202

Pariente N, Morizono K, Virk MS et al (2007) A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther 15:1973–1981

Pariente N, Mao SH, Morizono K et al (2008) Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J Gene Med 10:242–248

Parker DG, Brereton HM, Klebe S et al (2009) A steroid-inducible promoter for the cornea. Br J Ophthalmol 93:1255–1259

Philippe S, Sarkis C, Barkats M et al (2006) Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 103:17684–17689

Rattray AJ, Champoux JJ (1989) Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H. J Mol Biol 208:445–456

Reiser J, Lai Z, Zhang X et al (2000) Development of multigene and regulated lentivirus vectors. J Virol 74:10589–10599

Rill DR, Santana VM, Roberts WM et al (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380–383

Rowe HM, Lopes L, Brown N et al (2009) Expression of vFLIP in a lentiviral vaccine vector activates NF-kappaB, matures dendritic cells, and increases CD8+ T-cell responses. J Virol 83:1555–1562

Ryser MF, Roesler J, Gentsch M et al (2007) Gene therapy for chronic granulomatous disease. Expert Opin Biol Ther 7:1799–1809

Saez E, Nelson MC, Eshelman B et al (2000) Identification of ligands and coligands for the ecdysone-regulated gene switch. Proc Natl Acad Sci USA 97:14512–14517

Semple-Rowland SL, Eccles KS, Humberstone EJ (2007) Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters. Mol Vis 13:2001–2011

Seo E, Kim S, Jho EH (2009) Induction of cancer cell-specific death via MMP2 promoter dependent Bax expression. BMB Rep 42:217–222

Sirin O, Park F (2003) Regulating gene expression using self-inactivating lentiviral vectors containing the mifepristone-inducible system. Gene 323:67–77

Sirven A, Pflumio F, Zennou V et al (2000) The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96:4103–4110

Song XT, Evel-Kabler K, Shen L et al (2008) A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat Med 14:258–265

Springfeld C, von Messling V, Frenzke M et al (2006) Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases. Cancer Res 66:7694–7700

Szecsi J, Drury R, Josserand V et al (2006) Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions. Mol Ther 14:735–744

Szulc J, Wiznerowicz M, Sauvain MO et al (2006) A versatile tool for conditional gene expression and knockdown. Nat Methods 3:109–116

Tan PH, Beutelspacher SC, Xue SA et al (2005) Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 105:3824–3832

Terheggen HG, Lowenthal A, Lavinha F et al (1975) Unsuccessful trial of gene replacement in arginase deficiency. Z Kinderheilkd 119:1–3

Themis M, Waddington SN, Schmidt M et al (2005) Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 12:763–771

Throm RE, Ouma AA, Zhou S et al (2009) Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood 113:5104–5110

Uch R, Gerolami R, Faivre J et al (2003) Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences. Cancer Gene Ther 10:689–695

VandenDriessche T, Thorrez L, Naldini L et al (2002) Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100:813–822

Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291:1304–1351

Vigna E, Cavalieri S, Ailles L et al (2002) Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol Ther 5:252–261

Vogt VM, Simon MN (1999) Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy. J Virol 73:7050–7055

Waehler R, Russell SJ, Curiel DT (2007) Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8:573–587

Watanabe S, Temin HM (1982) Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc Natl Acad Sci USA 79:5986–5990

Watson JD, Crick FH (1953a) Genetical implications of the structure of deoxyribonucleic acid. Nature 171:964–967

Watson JD, Crick FH (1953b) Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171:737–738

Weiling F (1991) Historical study: Johann Gregor Mendel 1822–1884. Am J Med Genet 40:1–25; discussion 26

Williamson B (1982) Gene therapy. Nature 298:416–418

Wilmut I, Schnieke AE, McWhir J et al (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385:810–813

Xu Y, Darcy PK, Kershaw MH (2007) Tumor-specific dendritic cells generated by genetic redirection of Toll-like receptor signaling against the tumor-associated antigen, erbB2. Cancer Gene Ther 14:773–780

Yanez-Munoz RJ, Balaggan KS, MacNeil A et al (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12:348–353

Yu D, Chen D, Chiu C et al (2001) Prostate-specific targeting using PSA promoter-based lentiviral vectors. Cancer Gene Ther 8:628–635

Zhang J, Zou L, Liu Q et al (2009) Rapid generation of dendritic cell specific transgenic mice by lentiviral vectors. Transgenic Res 18:921–931

Zhao H, Pestina TI, Nasimuzzaman M et al (2009) Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene. Blood 113:5747–5756

Zufferey R, Nagy D, Mandel RJ et al (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871–875

Zufferey R, Dull T, Mandel RJ et al (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873–9880

Zufferey R, Donello JE, Trono D et al (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886–2892